The effect of clinically indicated liraglutide on pericoronary adipose tissue in type 2 diabetic patients

HIGHLIGHTS

  • who: Irmelin I. A. Biesenbach and collaborators from the Faculty of Health Science, University of Southern Denmark, Winsl have published the research work: The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients, in the Journal: Cardiovascular ue020erapeutics of 14/01/2023
  • what: The aim of this study was to investigate the effect of clinically indicated liraglutide on pericoronary adipose_tissue (PCAT) attenuation derived from CCTA, as a surrogate marker of pericoronary inflammation, in diabetic patients. The aim of the original study was to investigate the changes in plaque burden and . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?